JNC: Assessment of cardiac involvement in rare forms of amyloidosis using positron emission tomography/computed tomography with 124I-evuzamitide (124I-p5+14, AT-01) (Q2

JNC: Assessment of cardiac involvement in rare forms of amyloidosis using positron emission tomography/computed tomography with 124I-evuzamitide (124I-p5+14, AT-01) (Q2_26)

Availability

On-Demand

Access expires on Jun 19, 2027

Cost

Full Domestic Member: $0.00

Early-Career: $0.00

Emeritus: $0.00

Industry: $0.00

International Emerging Markets: $0.00

Full International Member: $0.00

Trainee: $0.00

Non-Physician (Member): $0.00

Physician (Non-Member): $50.00

Non-Physician (Non-Member): $50.00

Credit Offered

1 CME Credit

1 CE Credit

1 COP Credit

This Journal CME activity will review Assessment of cardiac involvement in rare forms of amyloidosis using positron emission tomography/computed tomography with ¹²⁴I-evuzamitide (¹²⁴I-p5+14, AT-01).

This activity is targeted at imaging professionals and is intended to provide the latest information on clinical practice and cutting-edge scientific advances in nuclear cardiology and cardiac imaging.

After reading and reflecting upon this article in the Journal of Nuclear Cardiology, the learner should be able to:

Recognize frequent and rare forms of amyloidosis affecting the heart
Describe the characteristics of ¹²⁴I-evuzamitide
Consider the potential utility of ¹²⁴I-evuzamitide PET/CT in rare forms of cardiac amyloidosis

The purpose of this CME activity in the Journal of Nuclear Cardiology is to increase the learners’ competence in the application of nuclear cardiology strategies in clinical practice.

Evaluation Deadlines: AMA PRA Category 1 Credits™, ARRT Category A, and Participation Credits = June 19, 2027

The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians: The American Society of Nuclear Cardiology designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education (CE) credit is accepted by both NMTCB and ARRT. This Journal-based activity has been approved for a maximum of 1 ARRT Category A credit for Technologists.

Release Date: June 20, 2026
Expiration Date: June 19, 2027

ASNC members may claim continuing education credits at no charge. Non-members will be charged $50 per activity.